Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Differential performance of nailfold video capillaroscopic parameteres in the diagnosis and prognosis of systemic sclerosis.

Bournia VK, Kottas K, Panopoulos S, Konstantonis G, Iliopoulos A, Tektonidou MG, Tzioufas AG, Sfikakis PP, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2020 Jan 14. [Epub ahead of print]

PMID:
31969216
2.

The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial.

Keramiotou K, Anagnostou C, Kataxaki E, Galanos A, Sfikakis PP, Tektonidou MG.

RMD Open. 2020 Jan;6(1). pii: e001141. doi: 10.1136/rmdopen-2019-001141.

3.

JAK inhibitors: promising for a wider spectrum of autoimmune diseases?

Tektonidou MG.

Lancet. 2019 Dec 7;394(10214):2047-2048. doi: 10.1016/S0140-6736(19)32681-9. Epub 2019 Nov 12. No abstract available.

PMID:
31732181
4.

Effect of belimumab treatment on antiphospholipid antibodies levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus.

Chatzidionysiou K, Samoli E, Sfikakis PP, Tektonidou MG.

Ann Rheum Dis. 2019 Nov 11. pii: annrheumdis-2019-216367. doi: 10.1136/annrheumdis-2019-216367. [Epub ahead of print] No abstract available.

PMID:
31712248
5.

Does seronegative obstetric APS exist? "pro" and "cons".

Conti F, Andreoli L, Crisafulli F, Mancuso S, Truglia S, Tektonidou MG.

Autoimmun Rev. 2019 Dec;18(12):102407. doi: 10.1016/j.autrev.2019.102407. Epub 2019 Oct 19. Review.

PMID:
31639518
6.

Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndrome.

Flessa CM, Vlachiotis S, Nezos A, Andreakos E, Mavragani CP, Tektonidou MG.

Clin Immunol. 2019 Dec;209:108265. doi: 10.1016/j.clim.2019.108265. Epub 2019 Oct 19.

PMID:
31639447
7.

Joint microwave radiometry for inflammatory arthritis assessment.

Laskari K, Pentazos G, Pitsilka D, Raftakis J, Konstantonis G, Toutouzas K, Siores E, Tektonidou M, Sfikakis PP.

Rheumatology (Oxford). 2019 Sep 5. pii: kez373. doi: 10.1093/rheumatology/kez373. [Epub ahead of print]

PMID:
31504966
8.

Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.

Vlachogiannis NI, Gatsiou A, Silvestris DA, Stamatelopoulos K, Tektonidou MG, Gallo A, Sfikakis PP, Stellos K.

J Autoimmun. 2020 Jan;106:102329. doi: 10.1016/j.jaut.2019.102329. Epub 2019 Sep 5.

9.

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR.

Arthritis Rheumatol. 2019 Sep;71(9):1400-1412. doi: 10.1002/art.40930. Epub 2019 Aug 6.

PMID:
31385462
10.

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR.

Ann Rheum Dis. 2019 Sep;78(9):1151-1159. doi: 10.1136/annrheumdis-2018-214819. Epub 2019 Aug 5. Review.

11.

Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications.

Xourgia E, Tektonidou MG.

J Autoimmun. 2019 Nov;104:102311. doi: 10.1016/j.jaut.2019.102311. Epub 2019 Aug 1. Review.

PMID:
31378637
12.

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.

Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H; APS ACTION.

J Thromb Haemost. 2019 Dec;17(12):2069-2080. doi: 10.1111/jth.14596. Epub 2019 Sep 8.

PMID:
31364274
13.

Silent Myocardial Perfusion Abnormalities Detected by Stress Cardiovascular Magnetic Resonance in Antiphospholipid Syndrome: A Case-Control Study.

Mavrogeni SI, Markousis-Mavrogenis G, Karapanagiotou O, Toutouzas K, Argyriou P, Velitsista S, Kanoupakis G, Apostolou D, Hautemann D, Sfikakis PP, Tektonidou MG.

J Clin Med. 2019 Jul 23;8(7). pii: E1084. doi: 10.3390/jcm8071084.

14.

Interhospital variation in mortality among patients with systemic lupus erythematosus and sepsis in the USA.

Tektonidou MG, Dasgupta A, Ward MM.

Rheumatology (Oxford). 2019 Oct 1;58(10):1794-1801. doi: 10.1093/rheumatology/kez103.

15.

Mechanics of early ventricular impairment in systemic sclerosis and the effects of peripheral arterial haemodynamics.

Tountas C, Protogerou AD, Bournia VK, Panopoulos S, Konstantonis G, Tektonidou MG, Gournizakis A, Beldekos D, Sfikakis PP.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):57-62. Epub 2019 Jun 4.

16.

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, Tincani A, Ward MM.

RMD Open. 2019 Apr 28;5(1):e000924. doi: 10.1136/rmdopen-2019-000924. eCollection 2019. Review.

17.

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity.

Panousis NI, Bertsias GK, Ongen H, Gergianaki I, Tektonidou MG, Trachana M, Romano-Palumbo L, Bielser D, Howald C, Pamfil C, Fanouriakis A, Kosmara D, Repa A, Sidiropoulos P, Dermitzakis ET, Boumpas DT.

Ann Rheum Dis. 2019 Aug;78(8):1079-1089. doi: 10.1136/annrheumdis-2018-214379. Epub 2019 Jun 5.

18.

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.

Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D; APS ACTION.

Semin Arthritis Rheum. 2019 Dec;49(3):464-468. doi: 10.1016/j.semarthrit.2019.04.009. Epub 2019 May 2.

PMID:
31153708
19.

EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM.

Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15.

PMID:
31092409
20.

The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through Synergy.

Sakkas LI, Bogdanos DP, Boumpas D, Mamouris Z, Gkoutzourelas A, Mavropoulos A, Tsouris Z, Liossis SN, Daoussis D, Vasilopoulos D, Tektonidou M, Tzioufas A, Efthymiou G, Dardiotis E, Kitas G, Sharif Κ, Blank M, Karussis D, Rimar D, Slobodin G, Porat-Katz BS, Vadasz Z, Amital H, Toubi E, Shoenfeld Y.

Isr Med Assoc J. 2019 Apr;21(4):292-297. No abstract available.

21.

Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations.

Palli E, Kravvariti E, Tektonidou MG.

Front Immunol. 2019 Mar 15;10:487. doi: 10.3389/fimmu.2019.00487. eCollection 2019.

22.

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.

Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML; APS ACTION.

Thromb Res. 2019 Mar;175:32-36. doi: 10.1016/j.thromres.2019.01.010. Epub 2019 Jan 18.

PMID:
30685523
23.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

24.

Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.

Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A, Sakkas L, Boumpas D, Voulgari PV, Daoussis D, Thomas K, Georgiopoulos G, Vosvotekas G, Vassilopoulos D, Sfikakis PP.

Arthritis Res Ther. 2018 Dec 4;20(1):267. doi: 10.1186/s13075-018-1771-0.

25.

Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.

RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

26.

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.

BJOG. 2019 Apr;126(5):656-661. doi: 10.1111/1471-0528.15469. Epub 2018 Oct 24.

PMID:
30222236
27.

Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.

Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.

Clin Rheumatol. 2019 Jan;38(1):125-132. doi: 10.1007/s10067-018-4267-z. Epub 2018 Aug 25.

PMID:
30145635
28.

Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.

Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG.

Rheumatology (Oxford). 2018 Dec 1;57(12):2158-2166. doi: 10.1093/rheumatology/key233.

PMID:
30102390
29.

Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.

Tektonidou MG.

Front Immunol. 2018 May 31;9:1181. doi: 10.3389/fimmu.2018.01181. eCollection 2018. Review.

30.

Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort.

Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP, Tektonidou MG.

Autoimmun Rev. 2018 Aug;17(8):816-820. doi: 10.1016/j.autrev.2018.02.008. Epub 2018 Jun 6.

PMID:
29885536
31.

B-cell activating factor and related genetic variants in lupus related atherosclerosis.

Theodorou E, Nezos A, Antypa E, Ioakeimidis D, Koutsilieris M, Tektonidou M, Moutsopoulos HM, Mavragani CP.

J Autoimmun. 2018 Aug;92:87-92. doi: 10.1016/j.jaut.2018.05.002. Epub 2018 May 31.

PMID:
29859654
32.

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.

Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584.

33.

Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.

Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.

Semin Arthritis Rheum. 2018 Dec;48(3):467-474. doi: 10.1016/j.semarthrit.2018.02.014. Epub 2018 Feb 23.

PMID:
29555348
34.

Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.

Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG.

Semin Arthritis Rheum. 2018 Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015. Epub 2017 Oct 23.

PMID:
29150207
35.

Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.

Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A, Tektonidou M, Lliossis SC, Daoussis D, Plastiras S, Karabela G, Stavropoulos E, Katsifis G, Vartela V, Kolovou G.

Lupus. 2018 Apr;27(4):564-571. doi: 10.1177/0961203317731533. Epub 2017 Sep 19.

PMID:
28927316
36.

Brief Report: Drug-Free Long-Term Remission in Severe Behçet's Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment.

Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K, Pentazos G, Laskari K, Tektonidou M, Markomichelakis N.

Arthritis Rheumatol. 2017 Dec;69(12):2380-2385. doi: 10.1002/art.40235. Epub 2017 Nov 8.

37.

Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016.

Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM.

Ann Rheum Dis. 2017 Dec;76(12):2009-2016. doi: 10.1136/annrheumdis-2017-211663. Epub 2017 Aug 9. Review. Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472.

PMID:
28794077
38.

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.

Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ, Gonzalez E, Knight JS, Uthman I, Willis R, Zhang Z, Wahl D, Zuily S, Tektonidou MG; APS ACTION.

Lupus. 2018 Mar;27(3):399-406. doi: 10.1177/0961203317724219. Epub 2017 Aug 1.

PMID:
28764618
39.

Reply.

Ward MM, Dasgupta A, Tektonidou M.

Arthritis Rheumatol. 2017 Aug;69(8):1705. doi: 10.1002/art.40115. Epub 2017 Jun 14. No abstract available.

40.

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.

Sfikakis PP, Bournia VK, Sidiropoulos P, Boumpas DT, Drosos AA, Kitas GD, Konstantonis G, Liossis SN, Manoussakis MN, Sakkas L, Tektonidou M, Tzioufas AG, Vlachoyiannopoulos PG, Kani C, Paterakis P, Litsa P, Vassilopoulos D.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):579-585. Epub 2017 Mar 3.

PMID:
28281458
41.

Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.

Sciascia S, Radin M, Yazdany J, Tektonidou M, Cecchi I, Roccatello D, Dall'Era M.

Rheumatol Int. 2017 Aug;37(8):1249-1255. doi: 10.1007/s00296-017-3686-5. Epub 2017 Mar 3. Review.

42.

Methodological Quality of Studies of Endstage Renal Disease in Lupus Nephritis, 1970 to 2015.

Tektonidou MG, Ward MM.

J Rheumatol. 2017 May;44(5):626-630. doi: 10.3899/jrheum.160546. Epub 2017 Feb 15. Review.

43.

Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases.

Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V, Kolovou G.

Int J Cardiol. 2017 Jun 1;236:151-156. doi: 10.1016/j.ijcard.2017.01.104. Epub 2017 Feb 1.

PMID:
28185705
44.

Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.

Tektonidou MG, Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Protogerou A.

Autoimmun Rev. 2017 Mar;16(3):308-312. doi: 10.1016/j.autrev.2017.01.009. Epub 2017 Jan 29.

PMID:
28147263
45.

Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012.

Tektonidou MG, Wang Z, Ward MM.

Arthritis Rheumatol. 2016 Nov;68(11):2680-2685. doi: 10.1002/art.39758.

46.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A.

Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25.

47.

Emerging Therapies in Antiphospholipid Syndrome.

Andrade D, Tektonidou M.

Curr Rheumatol Rep. 2016 Apr;18(4):22. doi: 10.1007/s11926-016-0566-z. Review.

PMID:
26995745
48.

Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis.

Tektonidou MG, Dasgupta A, Ward MM.

Arthritis Rheumatol. 2016 Jun;68(6):1432-41. doi: 10.1002/art.39594. Review.

49.

Cardiac involvement in antiphospholipid syndrome: The diagnostic role of noninvasive cardiac imaging.

Mavrogeni SI, Sfikakis PP, Kitas GD, Kolovou G, Tektonidou MG.

Semin Arthritis Rheum. 2016 Apr;45(5):611-6. doi: 10.1016/j.semarthrit.2015.09.005. Epub 2015 Oct 8. Review.

PMID:
26616201
50.

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.

Tamirou F, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, Houssiau FA; MAINTAIN Nephritis Trial Group.

Ann Rheum Dis. 2016 Mar;75(3):526-31. doi: 10.1136/annrheumdis-2014-206897. Epub 2015 Mar 10.

Supplemental Content

Loading ...
Support Center